Variation of hepatic methotrexate 7-hydroxylase activity in animals and humans

IUBMB Life

Volumn 48, Issue 6, 1999, Pages 607-611

  Kitamura, Shigeyuki ^a   Sugihara, Kazumi ^a   Nakatani, Keiko ^a   Ohta, Shigeru ^a   Oh Hara, Toshinari ^b   Ninomiya, Shin Ichi ^b   Green, Carol E ^c   Tyson, Charles A ^c  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b DAIICHI PURE CHEMICALS CO LTD   (Japan)

^c SRI INTERNATIONAL   (United States)

Author keywords

7 Hydroxymethotrexate; Aldehyde oxidase; Cytosolic hydroxylase; Human liver; Interindividual variation; Interspecies variation; Methotrexate

Indexed keywords

7 HYDROXYMETHOTREXATE; ALDEHYDE OXIDASE; METHOTREXATE; OXYGENASE;

ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ASSAY; HUMAN; HUMAN TISSUE; LIVER; NONHUMAN; SPECIES DIFFERENCE; STRAIN DIFFERENCE;

EID: 0033378603     PISSN: 15216543     EISSN: None     Source Type: Journal    
DOI: 10.1080/152165499306487     Document Type: Article

References (40)

1. Allegra, C. J. (1990) Antifolates. In Cancer Chemotherapy: Principles and Practice. (Chabner, B. A., and Collins, J. M., eds.), pp. 110-153, J. B. Lippincott Co., Philadelphia.
2. O'Dwyer, P. J., King, S. A., Hoth, D. F., and Leyland-Jones, B. (1987) Role of thymidine in biochemical modulation: A review. Cancer Res. 47, 3911-3919.
3. Niemeyer, C. M., Gelber, R. D., Tarbell, N. J., Donnelly, M., Clavell, L. A., Blattner, S. R., Donahue, K., Cohen, H. J., and Sallan, S. E. (1991) Low-dose versus high-dose methotrexate during remission induction in childhood acute lymphoblastic leukemia. Blood 78, 2514-2519.
4. Furst, D. E. (1997) The rational use of methotrexate in rheumatoid arthritis and other rheumatic diseases. Br. J. Rheumatol. 36, 1196-1204.
5. Weinblatt, M. E. (1991) Methotrexate: Mechanism of action, pharmacokinetics, clinical indications, and toxicity. Curr. Opin. Rheumatol. 3, 363-368.
6. Chabner, B. A., Allegra, C. J., Curt, G. A., Clendeninn, N. J., Baram, J., Koizumi, S., Drake, J. C., and Jolivet, J. (1985) Polyglutamation of methotrexate. Is methotrexate a prodrug? J. Clin. Invest. 76, 907-912.
7. Breithaupt, H., and Kuenzlen, E. (1982) Pharmacokinetics of methotrexate and 7-hydroxymethotrexate following infusion of high-dose methotrexate. Cancer Treat. Rep. 66, 1733-1741.
8. Bremnes, R. M., Slørdal, L., Wist, E., and Aarbakke, J. (1989) Formation and elimination of 7-hydroxymethotrexate in the rat in vivo after methotrexate administration. Cancer Res. 49, 2460-2464.
9. Lankelma, J., Van der Klein, E., and Ramaekers, F. (1980) The role of 7-hydroxymethotrexate during methotrexate anticancer chemotherapy. Cancer Lett. 9, 133-142.
10. 2) in childhood malignancies. Clinical tolerability and pharmacokinetics. Pediatr. Hematol. Oncol. 4, 33-42.
11. 10-methylpteroic acid after high-dose methotrexate. Clin. Pharmacol. Ther. 26, 63-72.
12. Smeland, E., Fuskevåg, O. M., Nymann, K., Svendsen, J. S., Olsen, R., Lindal, S., Bremnes, R. M., and Aarbakke, J. (1996) High-dose 7-hydroxymethotrexate: Acute toxicity and lethality in a rat model. Cancer Chemother. Pharmacol. 37, 415-422.
13. Fabre, G., Fabre, I., Matherly, L. H., Cano, J. P., and Goldman, I. D. (1984) Synthesis and properties of 7-hydroxymethotrexate polyglutamyl derivatives in Ehrlich ascites tumor cells in vitro. J. Biol. Chem. 259, 5066-5072.
14. Johns, D. G., Iannotti, A. T., Sartorelli, A. C., Booth, B. A., and Bertino, J. R. (1966) The relative toxicities of methotrexate and aminopterin. Biochem. Pharmacol. 15, 555-561.
15. Sasaki, K., Hosoya, R., Wang, Y.-M., and Raulston, G. L. (1983) Formation and disposition of 7-hydroxymethotrexate in rabbits. Biochem. Pharmacol. 32, 503-507.
16. Johns, D. G., Iannotti, A. T., Sartorelli, A. C., Booth, B. A., and Bertino, J. R. (1965) The identity of rabbit liver methotrexate oxidase. Biochim. Biophys. Acta 105, 380-382.
17. Rhee, M. S., and Galivan, J. (1986) Conversion of methotrexate to 7-hydroxymethotrexate and 7-hydroxymethotrexate polyglutamates in cultured rat hepatic cells. Cancer Res. 46, 3793-3797.
18. Kitamura, S., Nakatani, K., Sugihara, K., and Ohta, S. (1999) Strain differences of the ability to hydroxylate methotrexate in rats. Comp. Biochem. Physiol. 122C, 331-336.
19. Sugihara, K., Kitamura, S., and Tatsumi, K. (1995) Strain differences of liver aldehyde oxidase activity in rats. Biochem. Mol. Biol. Int. 37, 861-869.
20. Beedham, C. (1985) Molybdenum hydroxylases as drug-metabolizing enzymes. Drug Metab. Rev. 16, 119-156.
21. Beedham, C. (1987) Molybdenum hydroxylases: Biological distribution and substrate-inhibitor specificity. Prog. Med. Chem. 24, 85-121.
22. Kaye, B., Rance, D. J., and Waring, L. (1985) Oxidative metabolism of carbazeran in vitro by liver cytosol of baboon and man. Xenobiotica 15, 237-242.
23. Beedham, C., Critchley, D. J. P., and Rance, D. J. (1995) Substrate specificity of human liver aldehyde oxidase toward substituted quinazolines and phthalazines: A comparison with hepatic enzyme from guinea pig, rabbit, and baboon. Arch. Biochem. Biophys. 319, 481-490.
24. Kawashima, K., Hosoi, K., Naruke, T., Shiba, T., Kitamura, M., and Watabe, T. (1999) Aldehyde oxidase-dependent marked species difference in hepatic metabolism of the sedative-hypnotic, zeleplon, between monkeys and rats. Drug Metab. Dispos. 27, 422-428.
25. Hirao, Y., Kitamura, S., and Tatsumi, K. (1994) Epoxide reductase activity of mammalian liver cytosols and aldehyde oxidase. Carcinogenesis 15, 739-743.
26. Kitamura, S., Sugihara, K., and Tatsumi, K. (1997) Reductase activity of aldehyde oxidase toward the carcinogen N-hydroxy-2-acetylaminofluorene and the related hydroxamic acids. Biochem. Mol. Biol. Int. 34, 1197-1203.
27. Kitamura, S., and Tatsumi, K. (1983) Azoreductase activity of liver aldehyde oxidase. Chem. Pharm. Bull. 31, 3334-3337.
28. Kitamura, S., and Tatsumi, K. (1984) Reduction of tertiary amine N-oxides by liver preparations: Function of aldehyde oxidase as a major N-oxide reductase. Biochem. Biophys. Res. Commun. 121, 749-754.
29. Stoddart, A. M., and Levine, W. G. (1992) Azoreductase activity by purified rabbit liver aldehyde oxidase. Biochem. Pharmacol. 43, 2227-2235.
30. Sugihara, K., Kitamura, S., and Tatsumi, K. (1996) Involvement of mammalian liver cytosols and aldehyde oxidase in reductive metabolism of zonisamide. Drug Metab. Dispos. 24, 199-202.
31. Tatsumi, K., and Ishigai, M. (1987) Oxime-metabolizing activity of liver aldehyde oxidase. Arch. Biochem. Biophys. 253, 413-418.
32. Tatsumi, K., Kitamura, S., and Narai, N. (1986) Reductive metabolism of aromatic nitro compounds including carcinogens by rabbit liver preparations. Cancer Res. 46, 1089-1093.
33. 1-Methylnicotinamide oxidation in a number of mammals. J. Biol. Chem. 242, 1274-1279.
34. Krenitsky, T. A., Tuttle, J. V., Cattau, E. L., and Wang, P. (1974) A comparison of the distribution and electron acceptor specificities of xanthine oxidase and aldehyde oxidase. Comp. Biochem. Physiol. 48B, 687-703.
35. Sugihara, K., Kitamura, S., Tatsumi, K., Asahara, T., and Dohi, K. (1997) Differences in aldehyde oxidase activity in cytosolic preparations of human and monkey liver. Biochem. Mol. Biol. Int. 41, 1153-1160.
36. Rodrigues, A. D. (1994) Comparison of levels of aldehyde oxidase with cytochrome P450 activities in human liver in vitro. Biochem. Pharmacol. 48, 197-200.
37. Johns, D. G. (1967) Human liver aldehyde oxidase: Differential inhibition of oxidation charged and uncharged substrates. J. Clin. Invest. 46, 1492-1505.
38. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
39. 1-methylnicotinamide oxidase activity in mice. J. Biol. Chem. 242, 1265-1270.
40. 1-methylnicotinamide and pyridoxal. Arch. Biochem. Biophys. 145, 27-34.